EmilyABlumbergMD

Transplant/Immunocompromised States

Professor of Medicine/Infectious Diseases

Dr. Blumberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce Street
3 Silverstein, Suite D
Philadelphia, PA 19104
Phone+1 215-662-6932

Fax+1 215-662-7899

I am a board certified infectious diseases physician with a focus on infections in transplant patients.

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1984 - 1987
University of ChicagoResidency, Internal Medicine, 1981 - 1984
New York University School of MedicineClass of 1981

Philadelphia Magazine Castle Connolly, 2011-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Top Doctors - Philadelphia Magazine Philadelphia Magazine

PubMed

Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C-Viremic Donor Kidneys Into Uninfected Recipients: A Multi-Center Retrospective Cohort Study.
Vishnu S Potluri, David Goldberg, Siqi Zhang, Douglas E Schaubel, Miklos Z Molnar
Transplant Infectious Disease. 2025-03-06
Author response to Maribavir: Double Edged Sword.
Emily A Blumberg, Oliver Witzke, Mark Harber, Faouzi Saliba, Nassim Kamar
The Journal of Heart and Lung Transplantation. 2025-03-04
Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study.
Andrew M Courtwright, Stacey Prenner, Jeffrey B Doyon, Tamara Claridge, Emily Blumberg
Transplant Infectious Disease. 2025-02-24

Journal Articles

Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients
Janet Englund, Emily Blumberg, The Journal of Infectious Diseases
Twelve-Month Outcomes After Transplant of Hepatitis C–infected Kidneys into Uninfected Recipients: A Single-Group Trial
David S Goldberg, Roy D Bloom, Vishnu S Potluri, Susanna M Nazarian, Ali Naji, Emily A Blumberg, Peter L Abt, Peter P Reese, Matthew Levine, Paige Porrett, Melissa Ble..., Annals of Internal Medicine

STI Testing at Home? Survey Finds Many Young People Are for ItFebruary 14th, 2025
EBV Exposure Linked to Life-Threatening Cancer Risk in Kidney Transplant PatientsFebruary 9th, 2025
Penn Medicine-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation ResearchJanuary 4th, 2022
Join now to see all